12:00 AM
Aug 01, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oral Tobrate tobramycin: Phase I started

Enteris began a double-blind Phase I trial to evaluate single and multiple ascending doses of oral Tobrate in...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >